FDA Rubber-Stamps Remdesivir for Infants Without Evidence of Safety, Efficacy

The U.S. Food and Drug Administration on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants 4 weeks and older, despite having no evidence the treatment is effective or even safe for young children.

link

What’s worse Remdesivir is known to not work against covid and cause harm in adults. Calling Dr Marks! ABN

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s